By stratifying tumours into those having the highest MLK4 expression (highest 10% of all cases) and the lowest MLK4 expression (lowest 10% of all cases), we examined the difference in the transcriptome and the pathways which were associated with a higher level of MLK4 expression. The gene discussed is MAP3K21; the disease is neoplasm.